vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and YORK WATER CO (YORW). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $19.4M, roughly 1.6× YORK WATER CO). YORK WATER CO runs the higher net margin — 26.7% vs -32.1%, a 58.8% gap on every dollar of revenue. On growth, YORK WATER CO posted the faster year-over-year revenue change (3.2% vs -4.5%). Over the past eight quarters, YORK WATER CO's revenue compounded faster (5.1% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
The York Water Company is an investor-owned, public utility company based in York, Pennsylvania and operating throughout Pennsylvania. The company was founded in 1816 by a group of local businessmen concerned about fire protection.
LFCR vs YORW — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $19.4M |
| Net Profit | $-10.0M | $5.2M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 33.2% |
| Net Margin | -32.1% | 26.7% |
| Revenue YoY | -4.5% | 3.2% |
| Net Profit YoY | -52.0% | 0.5% |
| EPS (diluted) | $-0.29 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $19.4M | ||
| Q3 25 | $31.1M | $20.2M | ||
| Q2 25 | — | $19.1M | ||
| Q1 25 | $35.2M | $18.3M | ||
| Q4 24 | $32.6M | $18.8M | ||
| Q3 24 | $24.7M | $19.6M | ||
| Q2 24 | — | $18.6M | ||
| Q1 24 | $35.7M | $17.5M |
| Q4 25 | — | $5.2M | ||
| Q3 25 | $-10.0M | $6.2M | ||
| Q2 25 | — | $5.1M | ||
| Q1 25 | $-14.8M | $3.6M | ||
| Q4 24 | $-6.6M | $5.1M | ||
| Q3 24 | $-16.2M | $5.9M | ||
| Q2 24 | — | $5.0M | ||
| Q1 24 | $15.6M | $4.3M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | 33.2% | ||
| Q3 25 | -9.9% | 39.1% | ||
| Q2 25 | — | 37.1% | ||
| Q1 25 | -25.7% | 34.3% | ||
| Q4 24 | -6.0% | 35.8% | ||
| Q3 24 | -46.9% | 41.1% | ||
| Q2 24 | — | 37.9% | ||
| Q1 24 | -2.5% | 35.5% |
| Q4 25 | — | 26.7% | ||
| Q3 25 | -32.1% | 30.6% | ||
| Q2 25 | — | 26.5% | ||
| Q1 25 | -42.0% | 19.8% | ||
| Q4 24 | -20.2% | 27.4% | ||
| Q3 24 | -65.7% | 29.9% | ||
| Q2 24 | — | 26.8% | ||
| Q1 24 | 43.8% | 24.7% |
| Q4 25 | — | $0.36 | ||
| Q3 25 | $-0.29 | $0.43 | ||
| Q2 25 | — | $0.35 | ||
| Q1 25 | $-0.47 | $0.25 | ||
| Q4 24 | $-0.25 | $0.36 | ||
| Q3 24 | $-0.53 | $0.41 | ||
| Q2 24 | — | $0.35 | ||
| Q1 24 | $0.42 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $1.0K |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $240.3M |
| Total Assets | $235.2M | $680.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.0K | ||
| Q3 25 | $18.9M | $1.0K | ||
| Q2 25 | — | $1.0K | ||
| Q1 25 | $5.4M | $1.0K | ||
| Q4 24 | $9.5M | $1.0K | ||
| Q3 24 | — | $1.0K | ||
| Q2 24 | — | $1.0K | ||
| Q1 24 | — | $3.3M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $240.3M | ||
| Q3 25 | $-10.5M | $238.0M | ||
| Q2 25 | — | $234.6M | ||
| Q1 25 | $2.2M | $232.1M | ||
| Q4 24 | $15.4M | $231.2M | ||
| Q3 24 | $-3.9M | $228.7M | ||
| Q2 24 | — | $225.4M | ||
| Q1 24 | $17.7M | $222.9M |
| Q4 25 | — | $680.9M | ||
| Q3 25 | $235.2M | $667.1M | ||
| Q2 25 | — | $653.7M | ||
| Q1 25 | $237.7M | $641.8M | ||
| Q4 24 | $255.4M | $633.5M | ||
| Q3 24 | $246.8M | $621.4M | ||
| Q2 24 | — | $610.4M | ||
| Q1 24 | $246.2M | $602.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $8.4M |
| Free Cash FlowOCF − Capex | $25.0K | — |
| FCF MarginFCF / Revenue | 0.1% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | 1.63× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.4M | ||
| Q3 25 | $1.8M | $7.8M | ||
| Q2 25 | — | $7.6M | ||
| Q1 25 | $1.2M | $6.0M | ||
| Q4 24 | $-6.1M | $10.2M | ||
| Q3 24 | $-613.0K | $7.5M | ||
| Q2 24 | — | $6.7M | ||
| Q1 24 | $-1.4M | $6.1M |
| Q4 25 | — | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.3M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-4.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-7.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -12.1% | — | ||
| Q4 24 | -26.3% | — | ||
| Q3 24 | -16.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -21.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 17.8% | — |
| Q4 25 | — | 1.63× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 1.50× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.98× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 1.34× | ||
| Q1 24 | -0.09× | 1.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
YORW
Segment breakdown not available.
